When should polymyxin B-immobilized polystyrene column be introduced to improve COVID-19 prognosis?

Katagiri, Daisuke; Izumi, Shinyu; Takano, Hideki

Katagiri, Daisuke; Izumi, Shinyu; Takano, Hideki.

Katagiri D; Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.
Izumi S; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Takano H; Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.

Ther Apher Dial ; 26(3): 550-551, 2022 06.

Article in English | MEDLINE | ID: covidwho-1816499

Subject(s)

COVID-19; Hemoperfusion; Shock, Septic; Anti-Bacterial Agents/therapeutic use; Humans; Polymyxin B; Polystyrenes; Prognosis; Shock, Septic/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Shock, Septic / Hemoperfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Ther Apher Dial Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: 1744-9987.13825

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google